{"schema_version":"secwatch.filing_event.v1","accession":"0001615219-25-000080","form_type":"8-K","ticker":"DCOY","cik":"0001615219","company_name":"Decoy Therapeutics Inc.","filed_at":"2025-07-31T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.487936+00:00","generated_at":"2026-05-17T22:20:06.455378+00:00","sec_items":["2.02","3.02"],"event_type":"earnings","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Salarius Pharma expects Q2 net loss ~$900K, cash $800K; raises $3.8M via equity line","bullets":["Preliminary Q2 2025 net loss ~$900,000; cash at June 30 was $800,000.","Issued 5.5M shares under equity line for ~$3.8M gross proceeds post-quarter.","As of July 30, 2025, pro forma cash ~$4.5M after issuance.","Unregistered sale to C/M Capital Master Fund LP under purchase agreement.","Preliminary results are subject to adjustment; not yet audited."],"urls":{"canonical":"https://secwatch.observer/filing/0001615219-25-000080","json":"https://secwatch.observer/filing/0001615219-25-000080.json","markdown":"https://secwatch.observer/filing/0001615219-25-000080.md","text":"https://secwatch.observer/filing/0001615219-25-000080.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1615219/000161521925000080/0001615219-25-000080-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1615219/000161521925000080/flks-20250731.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T22:20:06.455378+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}